u/incretin_ivy

Good question and here is the actual reason rather than the reassurance.

The starting dose is a tolerability dose. Its job is to let your gut meet the drug gently. It is not expected to do much, and it was not expected to do much in the trials either.

On top of that, the half-life is around 168 hours, so it takes roughly four to five weeks of consistent dosing before you are at steady state on any given dose. At day 14 you are not yet at steady state on a dose that was never meant to produce an effect.

So: two independent reasons, both boring, both entirely expected. Your vial is almost certainly fine.

right, and that's kind of the whole argument for stretching it if your body's not cooperating — the trial pace optimised for trial length, not for any one person's stomach.

as someone who thinks about the biology side of this a lot: the mechanistic reality (appetite regulation returning to a prior set point once the drug effect fades) genuinely doesn't map well onto "relapse", which implies a choice or a slip. I'd support moving away from it, though I recognize changing community language is hard and slow.

Respectfully this is a sample of one presented as a finding.

that's a fair point and nobody in this thread suggested banning the word for self-description, just suggesting "regain" as the community's default framing rather than "relapse" as the assumed default

bit of both honestly. there's a real pharmacological piece — you're often still mid-titration around week 4-8, and the biggest satiety effects can lag the biggest dose increases by a couple weeks. but there's also a huge measurement-noise piece layered on top, and most people can't tell which one they're looking at.

lean mass retention is the 90 week conversation

Retitled to remove editorialising. Put the evidence in the body.

Hard agree. The food noise disappears differently on the two compounds.

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

Flair changed to match the content. Read the sidebar before posting next time and we are square.

not approved, descriptive posts only

Flair changed to match the content. Read the sidebar before posting next time and we are square.

pharmacologically this also lines up with steady-state timing after a dose step, roughly makes sense that a later stall reflects the drug level itself having settled rather than early noise

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

Strongly agree. Provincial variation is real.

no supplement selling, no coaching solicitation

regain after taper is expected, plan for it

Tried both. Sema worked, tirz worked better for me, but my nausea profile was worse on tirz.